CS logo
small CS logo
Colorado Allergy and Asthma Centers

Denver, Colorado, United States
Allergist in Denver, Colorado
125 Rampart Way Ste 100, Denver, CO 80230

About Colorado Allergy and Asthma Centers


"Over 45 Years of Research and Treatment in the Denver Metro Area! Here at Colorado Allergy & Asthma Centers®, our philosophy is to provide the highest quality, cost-effective medical care to adults and children who have asthma, allergies, and immune disorders. Our commitment to patient care and personalized treatment plans ensure that each patient’s individual needs are carefully considered and addressed. We are proud to offer full service, highly-specialized evaluations and treatments that are not readily found in local communities or academic institutions."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Colorado Allergy and Asthma Centers


During the past decade, Colorado Allergy and Asthma Centers conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 12 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Colorado Allergy and Asthma Centers" #1 sponsor was "Meda Pharmaceuticals" with 7 trials, followed by "Aimmune Therapeutics, Inc." with 3 trials sponsored, "Amphastar Pharmaceuticals, Inc." with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Teva Branded Pharmaceutical Products R&D, Inc." with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Colorado Allergy and Asthma Centers" #1 collaborator was "Pacira Pharmaceuticals, Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Colorado Allergy and Asthma Centers


According to Clinical.Site data, the most researched conditions in "Colorado Allergy and Asthma Centers" are "Asthma" (13 trials), "Seasonal Allergic Rhinitis" (6 trials), "Peanut Allergy" (3 trials), "Perennial Allergic Rhinitis" (3 trials) and "Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Colorado Allergy and Asthma Centers" in a lesser frequency.

Clinical Trials Intervention Types at Colorado Allergy and Asthma Centers


Most popular intervention types in "Colorado Allergy and Asthma Centers" are "Drug" (28 trials), "Biological" (7 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "AR101" (3 trials), "fluticasone propionate" (3 trials), "BLU-5937" (2 trials) and "azelastine Hcl" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Colorado Allergy and Asthma Centers


The vast majority of trials in "Colorado Allergy and Asthma Centers" are 35 trials for "All" genders.

Clinical Trials Status at Colorado Allergy and Asthma Centers


Currently, there are NaN active trials in "Colorado Allergy and Asthma Centers". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Colorado Allergy and Asthma Centers, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Colorado Allergy and Asthma Centers, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".